We'll get whacked today. Time to buy more if the price can go down enough...
This company certainly will need the money...very big scientific platform and agenda.
I hope you guys are right - I don't have too much experience with shelf offerings. My first instinct is "holy sh!t, over 20% dilution". I know this was announced previously, so it is expected. If there is a sell-off today, it's a great opportunity to LOAD UP!
The news release on Alnylam's website says the sale is public "Alnylam Announces Public Offering of Common Stock.
They are selling 5,115,961 which presumably equals their shelf of $75 million, which is therefore an offering at $14.66/share, or exactly at today's closing price.
I don't therefore anticipate any share price dilution and therefore no fluctuations in the stock other than we have seen already.
This doesn't answer my question.
What information leads you to believe the shelf is being exclusively offered to another Big Pharma????
I wish bloody Pfizer would have got in early on this one................
I am guessing the action will move the stock lower.
This is nonsensical IMHO though since the offering has been known about for quite a while.
We will see. In the scale of things (years) this is a non-event. It just means the company has more capital to reach its potential.
Personally it means I need to purchase another 1100 shares or so to stay standing still in terms of my percentage ownership. And I might if the stock pulls back a bit.